Swissmedic, Switzerland’s authority for therapeutic products, has announced the temporary authorization for the distribution of Abilify i.m. injection solution (7.5mg/ml) […]
On February 1, 2026, new blood donation criteria from Swiss Transfusion SRC will take effect, marking a critical update in
Spring & Mulberry Issues Recall of Mint Leaf Chocolate Bars Over Potential Salmonella Contamination On January 12, 2026, Spring &
The U.S. Food and Drug Administration (FDA) has issued new draft guidance aimed at streamlining clinical trials through the application
The U.S. Food and Drug Administration (FDA) has approved Zycubo (copper histidinate) injection, marking a significant regulatory milestone as the
On January 12, 2026, Swissmedic, the Swiss agency responsible for the authorization and monitoring of therapeutic products, announced a significant
Swissmedic, Switzerland’s national agency for therapeutic products, is offering a complimentary webinar on May 28, 2026. This online session will
The U.S. Food and Drug Administration (FDA) has awarded a national priority voucher for teclistamab in combination with daratumumab. This
The U.S. Food and Drug Administration (FDA) announced a significant regulatory update on January 12, 2026, aimed at expanding the
The U.S. Food and Drug Administration (FDA) has announced plans to enhance the effectiveness of food recalls. This comes after